Parkman Healthcare Partners’s Codexis CDXS Stock Holding History

Parkman Healthcare Partners’s Portfolio CDXS Stock Details CDXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-105,319	Closed	-$638K	–	85
2022 Q3	$638K	Sell	105,319 -98,730	-48%	-$794K	0.18%	82
2022 Q2	$2.13M	Sell	204,049 -64,095	-24%	-$804K	0.79%	42
2022 Q1	$5.53M	Sell	268,144 -72,008	-21%	-$1.49M	1.62%	21
2021 Q4	$10.6M	Buy	340,152 +54,085	+19%	+$1.78M	2.35%	15
2021 Q3	$6.65M	Buy	286,067 +80,000	+39%	+$1.89M	1.68%	22
2021 Q2	$4.67M	Buy	206,067 +106,067	+106%	+$2.3M	1.02%	37
2021 Q1	$2.29M	Buy	+100,000	New	+$2.34M	0.53%	51

Other funds holding CDXS

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Parkman Healthcare Partners's CDXS Position: Q4 2022 in Review

Parkman Healthcare Partners sold out of Codexis (CDXS) in Q4 2022, closing a stake of 105,319 shares — an estimated $638K sold.

Parkman Healthcare Partners first reported a position in CDXS in Q1 2021 and held it in 7 quarters. The position peaked at $10.6M in Q4 2021. 166 funds tracked by Wall St. Rank hold CDXS as of Q4 2022.

Parkman Healthcare Partners reported no remaining Codexis position as of Q4 2022 after selling out during the quarter.
Parkman Healthcare Partners sold 105,319 Codexis shares in Q4 2022, an estimated $638K.
Parkman Healthcare Partners first reported a position in Codexis in Q1 2021 and held it in 7 quarters.
Parkman Healthcare Partners's Codexis position peaked at $10.6M in Q4 2021.
166 funds tracked by Wall St. Rank held Codexis as of Q4 2022.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.